Navigation Links
Lakewood-Amedex, Inc. Appoints William J. Robison, Former Executive Vice President of Pfizer, as Board Member
Date:3/10/2009

SARASOTA, Fla., March 10 /PRNewswire/ -- Lakewood-Amedex, Inc., (L-A), the anti-infectives biopharmaceutical company developing a unique portfolio of anti-bacterial and anti-viral products including NuBiotics(R), a novel family of synthetic anti-bacterial compounds, announced today the appointment of William J. Robison, a former Pfizer senior executive, to the company's Board of Directors.

Mr. Robison most recently was an Executive Vice President of Pfizer, Inc. until he retired in 2001. He joined Pfizer, Inc. in 1961 and served within Pfizer's pharmaceutical sales organization to become Senior Vice President of Sales for Pfizer Labs. He was subsequently named General Manager for Pratt Pharmaceuticals and in 1992 was named President of Pfizer's Consumer Healthcare Group and made a Pfizer Corporate Officer. In 1996 he joined Pfizer's Corporate Management Committee and was promoted to the position of Executive Vice President and Head of Worldwide Corporate Employee Resources.

Mr. Robison currently serves as a director of several healthcare companies and is also on the Board of Trustees of the University of Louisiana-Monroe. He is a Founding Member of the United States Marine Corps Museum. Mr. Robison received a BS in Mathematics from the University of Louisiana-Monroe.

Steve Parkinson, L-A's President and Chief Executive Officer, commented, "We're delighted to have this highly experienced and respected pharmaceutical professional on our Board. Mr. Robison broadens our existing scientific and medical expertise and he will be especially valuable as we start to develop strategic collaborations with potential large pharmaceutical partners."

Mr. Robison said, "It is a great pleasure to be a part of an exciting and growing company like Lakewood-Amedex. Its broad anti-bacterial and targeted anti-viral products hold great promise for the healthcare industry and could save n
'/>"/>

SOURCE Lakewood-Amedex, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. PURE Bioscience Board Appoints John J. Carbone, MD to Board of Directors
2. China-Biotics, Inc. Appoints New Chief Financial Officer
3. Agendia Appoints Seasoned Diagnostics Executive Albert A. Luderer to Supervisory Board
4. Mindray Appoints Mr. Ronald Ede as Chief Financial Officer
5. Savara Expands Board of Directors, Appoints Three New Members
6. Informed Medical Communications Appoints New Senior Manager, Strategic Operations
7. Pearl Therapeutics Appoints Perry Karsen as Chief Executive Officer
8. Axial Biotech Appoints Dr. Roberto Macina to Vice President of Research and Development
9. Texcel Medical Appoints Barry Smith as President, CEO
10. SPO Medical Appoints New US Sales Rep Groups
11. iZumi Bio, Inc., Appoints John Walker as Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... , July 28, 2015  Moerae Matrix Inc. ... 1 clinical trial with MMI-0100, a first-in-class inhibitor ... developed for pulmonary disorders characterized by inflammation and ... United Kingdom , is a double-blind, two-way ... the safety and tolerability of MMI-0100 when given ...
(Date:7/28/2015)... ZIONA, Israel , July ... (TASE:CLPT; OTC:CQPTY), a regenerative medicine company utilizing its ... today announced that Shomrat Shurtz has been appointed ... 2015.      (Photo: http://photos.prnewswire.com/prnh/20150728/246955 ... 25 years of experience in marketing, regulatory and ...
(Date:7/27/2015)... Dallas, TX (PRWEB) , ... July 27, 2015 ... ... the current state of the Biophotonics industry.The report provides a basic overview of ... analysis is provided for the international markets including development trends, competitive landscape analysis, ...
(Date:7/27/2015)... ... July 27, 2015 , ... ... network Monday. The venture will bring the world’s most efficient gas dissolution technology ... equipment and technologies to both the industrial and municipal markets. With offices located ...
Breaking Biology Technology:Moerae Initiates Lipopolysaccharide (LPS) Challenge Study of Inhaled MMI-0100 for Pulmonary Disease Following Encouraging Safety and Tolerability Observed in Single Ascending Dose Phase 1 Study 2CollPlant Names Shomrat Shurtz Senior Director of Business Development 22015 Biophotonics Market Global Research 22015 Biophotonics Market Global Research 3BlueInGreen Brings Water Treatment Technology to Florida 2
... Aug. 7 Novavax, Inc. (Nasdaq: NVAX ) today reported a ... of 2009 compared to a net loss of $9.4 million, or $0.15 per ... For the six months ended June 30, 2009, Novavax reported a net ... loss of $17.1 million, or $0.28 per share, for the six months ended ...
... , , BRISBANE, Calif., Aug. 7 ... Dan Welch, Chairman, Chief Executive Officer and President of InterMune, will ... Boston on August 12, 2009 at 10:30 a.m. EDT. , ... presentation, investors and other interested parties may log on to the ...
... , , SALEM, N.H., Aug. 7 ALPCO Diagnostics ... c tin EL I SA kit ... it is a departure from other methods for determining mouse HMW adiponectin ... Dr. Hiroyuki Ebinuma of the Tsukuba Research Institute in the journal Clinica ...
Cached Biology Technology:Novavax Reports Second Quarter 2009 Financial Results 2Novavax Reports Second Quarter 2009 Financial Results 3Novavax Reports Second Quarter 2009 Financial Results 4Novavax Reports Second Quarter 2009 Financial Results 5Novavax Reports Second Quarter 2009 Financial Results 6Novavax Reports Second Quarter 2009 Financial Results 7Novavax Reports Second Quarter 2009 Financial Results 8Novavax Reports Second Quarter 2009 Financial Results 9ALPCO Introduces a Mouse HMW and Total Adiponectin ELISA 2
(Date:6/30/2015)... June 30, 2015 To bolster its efforts and ... Corp. announced today the addition of two new team members. ... board advisor and David Raviv will act as ... HYPR Corp.,s commitment to providing the most secure solutions for ... co-founded Layer 7 Technologies, a provider of security and ...
(Date:6/25/2015)... June 25, 2015 According ... Type (Swipe & Area), Technology, Material (Optical Prism, ... Commercial Security & Others) & Geography - Global ... the said market is expected to reach $14,500.07 ... Browse 76 market Tables and ...
(Date:6/24/2015)... YORK , June 24, 2015 This ... market, over the next six years. It contains an ... the industry, along with their impact from the short, ... It also discusses the industry, market, and technology trends ... that the need of concerned authorities to efficiently manage ...
Breaking Biology News(10 mins):HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 2Fingerprint Sensors Market Worth $14,500.07 Million by 2020 3Fingerprint Sensors Market Worth $14,500.07 Million by 2020 4Automatic Identification System Market by Class, by Platform, by Application and by Geography - Global Forecasts & Analysis to 2014 - 2020 2
... computer-imaging technology to produce stunning three-dimensional pictures of ... piece of fossilized amber resin. University of ... the intricate images using X-ray computed tomography to ... seen under the microscope in the old and ...
... available in German . , "Seeing something ... Joachim Fischer and Tolga Ergin. For about one year, both ... at KIT,s Center for Functional Nanostructures (CFN) have worked on ... an extent that it is also effective in the visible ...
... in your spring garden may still be struggling to reach the ... within each seed. Once those resources are depleted, the plant cell ... Researchers at the Salk Institute for Biological Studies recently showed a ... published in the May 24, 2011, issue of the journal ...
Cached Biology News:Imaging technology reveals intricate details of 49-million-year-old spider 2Karlsruhe invisibility cloak: Disappearing visibly 2It's not easy being green 2It's not easy being green 3
COMING SOON: Anti-Mouse CD205 (DEC-205),Clone NLDC-145, mAb...
... clone 41D GenBank Accession Number ... clusterin purified from human serum Formulation: ... and 0.05% sodium azide Quality Assurance: ... HeLa cells or MCF-7 cell lysates. ...
Component in MasterPure™ Purification Kits...
Mouse monoclonal [TU-20] to beta III Tubulin (FITC) ( Abpromise for all tested applications). entrezGeneID: 10381 SwissProtID: Q13509...
Biology Products: